Hui Li
Pfizer Global Research and Development
La Jolla Laboratories
10770 Science Center Drive
San Diego
USA
Name/email consistency: high
- Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges. Li, H., Shi, S.T. Future. Med. Chem (2010)
- Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor. Li, H., Tatlock, J., Linton, A., Gonzalez, J., Jewell, T., Patel, L., Ludlum, S., Drowns, M., Rahavendran, S.V., Skor, H., Hunter, R., Shi, S.T., Herlihy, K.J., Parge, H., Hickey, M., Yu, X., Chau, F., Nonomiya, J., Lewis, C. J. Med. Chem. (2009)
- Allosteric inhibitors of hepatitis C polymerase: discovery of potent and orally bioavailable carbon-linked dihydropyrones. Li, H., Linton, A., Tatlock, J., Gonzalez, J., Borchardt, A., Abreo, M., Jewell, T., Patel, L., Drowns, M., Ludlum, S., Goble, M., Yang, M., Blazel, J., Rahavendran, R., Skor, H., Shi, S., Lewis, C., Fuhrman, S. J. Med. Chem. (2007)
- Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors. Li, H., Tatlock, J., Linton, A., Gonzalez, J., Borchardt, A., Dragovich, P., Jewell, T., Prins, T., Zhou, R., Blazel, J., Parge, H., Love, R., Hickey, M., Doan, C., Shi, S., Duggal, R., Lewis, C., Fuhrman, S. Bioorg. Med. Chem. Lett. (2006)
